Amivantamab Plus Pembrolizumab in Previously Untreated Recurrent/Metastatic Head & Neck Squamous Cell Cancer: Results From the Phase 1b/2 OrigAMI-4 Study

International Journal of Radiation Oncology*Biology*Physics 2026

View at publisher
Authors: R. Mehra, H.F. Kao, H. J. Wang, M.S. Sandhu, W. Ince, A. Mehta, M. Oliva, E. Pawlowska, M.J. Ahn, A. Bhatia, B. Keam, P.L. Swiecicki
+6 more A. Sukari, K. Toyoizumi, M. Wade, E. Yilmaz, S. Shah, K. Harrington
DOI: 10.1016/j.ijrobp.2026.02.050
Cited by: 1

Fields of Study & Subjects

Head and Neck Cancer Studies Cancer Immunotherapy and Biomarkers Nonmelanoma Skin Cancer Studies

Publication details

Journal / source
International Journal of Radiation Oncology*Biology*Physics
Publisher
Elsevier BV
Volume
125
Issue
1
Pages
e25–e25
Publication date
16 April 2026
Language
EN